文献速递炎症性肠病

SLC26A6缺失与肠道菌群失调、屏障完整性受损及炎症的直接关联

A Direct Link Implicating Loss of SLC26A6 to Gut Microbial Dysbiosis, Compromised Barrier Integrity, and Inflammation.
PubMed 文献 · Gastroenterology · 2024-05-11

该研究以PAT1(SLC26A6)敲除小鼠与野生型同窝对照为对象,给予3.5%葡聚糖硫酸钠饮水6天,发现PAT1敲除小鼠体重下降、肠道通透性增高、结肠炎症和腹泻更明显,并出现菌群失调及丁酸和产丁酸菌显著减少;共饲养4周可使野生型小鼠结肠紧密连接蛋白表达出现类似敲除小鼠的改变。作者认为PAT1缺失破坏肠道菌群及相关代谢物、降低肠道屏障完整性并增加宿主对肠道炎症的易感性。

要点

  • PAT1敲除小鼠在3.5%葡聚糖硫酸钠处理下体重下降、肠道通透性、结肠炎症和腹泻均显著高于野生型。
  • PAT1敲除小鼠出现菌群失调,丁酸及产丁酸菌水平较对照显著降低。
  • 野生型与PAT1敲除小鼠共饲养4周后,野生型小鼠结肠紧密连接蛋白表达出现类似敲除小鼠的改变。

核心结论

  • PAT1(SLC26A6)缺失破坏肠道菌群及相关代谢物、降低肠道屏障完整性并增加宿主对肠道炎症的易感性。
  • 作者认为PAT1在促进肠道屏障完整性方面具有新作用,其缺失似乎参与炎症性肠病的发病机制。

研究设计与样本

  • 研究将年龄匹配的PAT1敲除小鼠与野生型同窝小鼠分为对照及处理组,处理组饮用含3.5%葡聚糖硫酸钠的水6天。
  • 收集对照组与处理组小鼠的回肠和结肠。
  • 采用逆转录聚合酶链反应和蛋白质印迹检测紧密连接蛋白的信使RNA和蛋白表达。
  • 通过腹泻表型、细胞因子表达和苏木精-伊红染色评估炎症严重程度。
  • 分别采用16S核糖体RNA测序和质谱分析肠道菌群及相关代谢组。

主要发现

  • PAT1敲除小鼠在葡聚糖硫酸钠处理后体重下降、肠道通透性、结肠炎症和腹泻均显著高于野生型。
  • PAT1敲除小鼠出现菌群失调,丁酸及产丁酸菌水平较对照显著降低。
  • 野生型与PAT1敲除小鼠共饲养4周后,野生型小鼠结肠紧密连接蛋白表达出现类似PAT1敲除小鼠的改变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Putative anion transporter-1 (PAT1, SLC26A6) plays a key role in intestinal oxalate and bicarbonate secretion. PAT1 knockout (PKO) mice exhibit hyperoxaluria and nephrolithiasis. Notably, diseases such as inflammatory bowel disease are also associated with higher risk of hyperoxaluria and nephrolithiasis. However, the potential role of PAT1 deficiency in gut-barrier integrity and susceptibility to colitis is currently elusive. METHODS: Age-matched PKO and wild-type littermates were administered 3.5% dextran sulfate sodium in drinking water for 6 days. Ileum and colon of control and treated mice were harvested. Messenger RNA and protein expression of tight junction proteins were determined by reverse transcription polymerase chain reaction and western blotting. Severity of inflammation was assessed by measuring diarrheal phenotype, cytokine expression, and hematoxylin and eosin staining. Gut microbiome and associated metabolome were analyzed by 16S ribosomal RNA sequencing and mass spectrometry, respectively. RESULTS: PKO mice exhibited significantly higher loss of body weight, gut permeability, colonic inflammation, and diarrhea in response to dextran sulfate sodium treatment. In addition, PKO mice showed microbial dysbiosis and significantly reduced levels of butyrate and butyrate-producing microbes compared with controls. Co-housing wild-type and PKO mice for 4 weeks resulted in PKO-like signatures on the expression of tight junction proteins in the colons of wild-type mice. CONCLUSIONS: Our data demonstrate that loss of PAT1 disrupts gut microbiome and related metabolites, decreases gut-barrier integrity, and increases host susceptibility to intestinal inflammation. These findings, thus, highlight a novel role of the oxalate transporter PAT1 in promoting gut-barrier integrity, and its deficiency appears to contribute to the pathogenesis of inflammatory bowel diseases.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Anbazhagan AN, Ge Y, Priyamvada S, et al. A Direct Link Implicating Loss of SLC26A6 to Gut Microbial Dysbiosis, Compromised Barrier Integrity, and Inflammation. Gastroenterology. 2024. PMID: 38735402. doi:10.1053/j.gastro.2024.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。